← All trials
NCT01277497
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Jan 1, 2016
- Completion date
- Mar 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Albany College of Pharmacy and Health SciencesLead sponsor
- Albany College of Pharmacy and Health SciencesOverall official - principal investigator
- Albany Medical CollegeCollaborator
- GenzymeCollaborator
- Albany College of Pharmacy and Health SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.